Terns Pharmaceuticals Stock Forecast for 2023 - 2025 - 2030
Updated on 05/13/2024
Terns Pharmaceuticals Stock Forecast and Price Target
Terns Pharmaceuticals's stock price reaches the average target of $15.00 by 2025 as expected recently by seven notable experts, there would be a potential upside of approximately 169.78% from the last closing price in May, 2024. This possible increase is based on a high estimate of $22.00 and a low estimate of $5.50.
169.78% Upside
Terns Pharmaceuticals Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Terns Pharmaceuticals's Price has grown by 100.00%, rising from $0.00 to $0.00. For next year, analysts predict Fair Value of $0.00, which would mean an increase of 100.00%. Over the next six years, experts predict that Terns Pharmaceuticals's Fair Value will grow at a rate of 100.00%.
.jpg)
Terns Pharmaceuticals EBITDA Forecast for 2023 - 2025 - 2030
Terns Pharmaceuticals's EBITDA has seen impressive growth In the last two years, rising from $-36.63M to $-61.55M – a growth of 68.03%. For the next year, 0 analysts project Terns Pharmaceuticals's EBITDA to drop by 21.81%, reaching $-48.13M. By 2030, professionals believe that Terns Pharmaceuticals's EBITDA will decrease by 19.21%, reaching $-49.73M – a concerning trend for the company.
Terns Pharmaceuticals EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Terns Pharmaceuticals's EBIT has grown by 67.51%, rising from $-37.03M to $-62.03M. According to 0 prominent analysts, Terns Pharmaceuticals's EBIT will fall by 21.66% in the next year, reaching $-48.60M. By 2030, professionals believe that Terns Pharmaceuticals's EBIT will decrease by 19.09%, reaching $-50.19M – a concerning trend for the company.
Terns Pharmaceuticals EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Terns Pharmaceuticals's EPS has grown by 100.00%, rising from $-102.93 to $0.00. For next year, analysts predict EPS of $0.00, which would mean an increase of 100.00%. Over the next six years, experts predict that Terns Pharmaceuticals's EPS will grow at a rate of 100.00%.
Site Navigation
.jpg)